Table 2 Rates of appropriate override by provider type, drug type, prescription type, and override reason(s)
| Â | No. of appropriate overrides/no. of overridden alerts (%) | ||
|---|---|---|---|
Physicians (n = 21) | Nurse practitioners (n = 9) | Total | |
Drug type | |||
Metformin | 25/79 (31.6) | 11/37 (29.7) | 36/116 (31.0) |
HCTZ | 18/50 (36.0) | 5/16 (31.3) | 23/66 (34.8) |
Glyburide | 12/26 (46.2) | 1/8 (12.5) | 13/34 (38.2) |
Nitrofurantoin | 2/12 (16.7) | 0/14 (0.0) | 2/26 (7.7) |
Others†| 0/6 (0.0) | 0/14 (0.0) | 0/20 (0.0) |
Prescription types | |||
New | 2/23 (8.7) | 0/21 (0.0) | 2/43 (4.7) |
Renew | 55/150 (36.7) | 17/56 (30.4) | 72/201 (35.8) |
Override reasons | |||
Patient has tolerated this drug in the past | 43/123 (35.0) | 15/57 (26.3) | 58/180 (32.2) |
New evidence supports therapy of this type | 8/18 (44.4) | 0/2 (0.0) | 8/20 (40.0) |
Advice from a consultant | 1/1 (100.0) | 0/2 (0.0) | 1/3 (33.3) |
Other‡ | 5/31 (16.1) | 2/16 (12.5) | 7/47 (14.9) |
Total | 57/173 (32.9) | 17/77 (22.1) | 74/250 (29.6) |